株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のポイントオブケア (POC) 凝固検査市場:2020年~2024年の予測

Global Point-of-Care Coagulation Testing MARKET 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 370793
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.59円で換算しております。
世界のポイントオブケア (POC) 凝固検査市場:2020年~2024年の予測 Global Point-of-Care Coagulation Testing MARKET 2020-2024
出版日: 2020年02月20日 ページ情報: 英文 120 Pages
概要

世界のポイントオブケア (POC) 凝固検査市場は、予測期間中に6%のCAGRで成長する見通しで、2024年には10億米ドルに達すると予測されています。同市場の成長は、高齢者人口の増加に牽引されています。また、個別化医療への注目が高まることにより、同市場の成長が促進されると期待されています。

当レポートは世界のポイントオブケア (POC) 凝固検査市場について調査しており、市場成長要因、動向や課題、エンドユーザー・地域別の市場分析、ベンダー情勢、主要企業のプロファイル等の情報を提供しています。

目次

エグゼクティブサマリー

  • 市場概況

市場の見通し

  • 市場エコシステム
  • バリューチェーン分析

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2019年
  • 市場の見通し:2019-2024年の予測

ファイブフォース分析

  • ファイブフォースサマリー
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

市場分析:エンドユーザー別

  • 市場セグメンテーション
  • 比較
  • 病院および診療所
  • 在宅医療
  • 市場機会

顧客の情勢

  • 概要

市場分析:地域別

  • セグメンテーション
  • 比較
  • 北米
  • 欧州
  • アジア
  • その他
  • 主要国
  • 市場機会

市場成長要因、課題、および動向

  • 市場成長要因
  • 取引量成長要因:需要主導の成長
  • 取引量成長要因:供給主導の成長
  • 取引量成長要因:外部要因
  • 取引量成長要因:関連市場での需要の移行
  • 価格成長要因:インフレ
  • 価格成長要因:低価格から高価格への移行
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 情勢の革新

企業プロファイル

  • 対象ベンダー
  • ベンダーの市場での位置づけ
  • Abbott Laboratories
  • Danaher Corp.
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • Helena Laboratories Corp.
  • iLine Microsystems SL
  • Medtronic Plc
  • Micropoint Bioscience Inc.
  • Siemens Healthineers AG
  • シスメックス株式会社

付録

  • レポートの範囲
  • 米ドルの為替レート
  • 調査方法
  • 略語のリスト
目次
Product Code: IRTNTR40479

Technavio has been monitoring the global point-of-care coagulation testing market and it is poised to grow by USD 1 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on global point-of-care coagulation testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population.In addition, growing focus toward personalized medicine is anticipated to boost the growth of the global point-of-care coagulation testing market as well.

Market Segmentation

Technavio's global point-of-care coagulation testing market is segmented as below:

End-Users:

  • Hospitals And Clinics
  • Homecare

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global point-of-care coagulation testing market growth

This study identifies growing focus toward personalized medicine as the prime reasons driving the global point-of-care coagulation testing market growth during the next few years.

Prominent vendors in global point-of-care coagulation testing market

We provide a detailed analysis of around 25 vendors operating in the global point-of-care coagulation testing market, including some of the vendors such as Abbott Laboratories, Danaher Corp., Diagnostica Stago SAS, F. Hoffmann-La Roche Ltd., Helena Laboratories Corp., iLine Microsystems SL, Medtronic Plc, Micropoint Bioscience Inc., Siemens Healthineers AG and Sysmex Corp. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Hospitals and clinics - Market size and forecast 2019-2024
  • Homecare - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Danaher Corp.
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • Helena Laboratories Corp.
  • iLine Microsystems SL
  • Medtronic Plc
  • Micropoint Bioscience Inc.
  • Siemens Healthineers AG
  • Sysmex Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Hospitals and clinics - Market size and forecast 2019-2024 ($ million)
  • 25.Hospitals and clinics - Year-over-year growth 2019-2024 (%)
  • 26.Homecare - Market size and forecast 2019-2024 ($ million)
  • 27.Homecare - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by End user
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.Asia - Market size and forecast 2019-2024 ($ million)
  • 37.Asia - Year-over-year growth 2019-2024 (%)
  • 38.ROW - Market size and forecast 2019-2024 ($ million)
  • 39.ROW - Year-over-year growth 2019-2024 (%)
  • 40.Key leading countries
  • 41.Market opportunity by geography ($ million)
  • 42.Impact of drivers
  • 43.Impact of challenges
  • 44.Landscape disruption
  • 45.Industry risks
  • 46.Vendors covered
  • 47.Market positioning of vendors
  • 48.Abbott Laboratories - Overview (1/3)
  • 49.Abbott Laboratories - Overview (2/3)
  • 50.Abbott Laboratories - Overview (3/3)
  • 51.Abbott Laboratories - Business segments
  • 52.Abbott Laboratories - Key offerings
  • 53.Abbott Laboratories - Key customers
  • 54.Abbott Laboratories - Segment focus
  • 55.Danaher Corp. - Overview (1/3)
  • 56.Danaher Corp. - Overview (2/3)
  • 57.Danaher Corp. - Overview (3/3)
  • 58.Danaher Corp. - Business segments
  • 59.Danaher Corp. - Key offerings
  • 60.Danaher Corp. - Key customers
  • 61.Danaher Corp. - Segment focus
  • 62.Diagnostica Stago SAS - Overview (1/3)
  • 63.Diagnostica Stago SAS - Overview (2/3)
  • 64.Diagnostica Stago SAS - Overview (3/3)
  • 65.Diagnostica Stago SAS - Product and service
  • 66.Diagnostica Stago SAS - Key offerings
  • 67.Diagnostica Stago SAS - Key customers
  • 68.Diagnostica Stago SAS - Segment focus
  • 69.F. Hoffmann-La Roche Ltd. - Overview (1/3)
  • 70.F. Hoffmann-La Roche Ltd. - Overview (2/3)
  • 71.F. Hoffmann-La Roche Ltd. - Overview (3/3)
  • 72.F. Hoffmann-La Roche Ltd. - Business segments
  • 73.F. Hoffmann-La Roche Ltd. - Key offerings
  • 74.F. Hoffmann-La Roche Ltd. - Key customers
  • 75.F. Hoffmann-La Roche Ltd. - Segment focus
  • 76.Helena Laboratories Corp. - Overview (1/3)
  • 77.Helena Laboratories Corp. - Overview (2/3)
  • 78.Helena Laboratories Corp. - Overview (3/3)
  • 79.Helena Laboratories Corp. - Product and service
  • 80.Helena Laboratories Corp. - Key offerings
  • 81.Helena Laboratories Corp. - Key customers
  • 82.Helena Laboratories Corp. - Segment focus
  • 83.iLine Microsystems SL - Overview (1/3)
  • 84.iLine Microsystems SL - Overview (2/3)
  • 85.iLine Microsystems SL - Overview (3/3)
  • 86.iLine Microsystems SL - Product and service
  • 87.iLine Microsystems SL - Key offerings
  • 88.iLine Microsystems SL - Key customers
  • 89.iLine Microsystems SL - Segment focus
  • 90.Medtronic Plc - Overview (1/3)
  • 91.Medtronic Plc - Overview (2/3)
  • 92.Medtronic Plc - Overview (3/3)
  • 93.Medtronic Plc - Business segments
  • 94.Medtronic Plc - Key offerings
  • 95.Medtronic Plc - Key customers
  • 96.Medtronic Plc - Segment focus
  • 97.Micropoint Bioscience Inc. - Overview (1/3)
  • 98.Micropoint Bioscience Inc. - Overview (2/3)
  • 99.Micropoint Bioscience Inc. - Overview (3/3)
  • 100.Micropoint Bioscience Inc. - Business segments
  • 101.Micropoint Bioscience Inc. - Key offerings
  • 102.Micropoint Bioscience Inc. - Key customers
  • 103.Micropoint Bioscience Inc. - Segment focus
  • 104.Siemens Healthineers AG - Overview (1/3)
  • 105.Siemens Healthineers AG - Overview (2/3)
  • 106.Siemens Healthineers AG - Overview (3/3)
  • 107.Siemens Healthineers AG - Business segments
  • 108.Siemens Healthineers AG - Key offerings
  • 109.Siemens Healthineers AG - Key customers
  • 110.Siemens Healthineers AG - Segment focus
  • 111.Sysmex Corp. - Overview (1/3)
  • 112.Sysmex Corp. - Overview (2/3)
  • 113.Sysmex Corp. - Overview (3/3)
  • 114.Sysmex Corp. - Business segments
  • 115.Sysmex Corp. - Key offerings
  • 116.Sysmex Corp. - Key customers
  • 117.Sysmex Corp. - Segment focus
  • 118.Currency conversion rates for US$
  • 119.Research Methodology
  • 120.Validation techniques employed for market sizing
  • 121.Information sources
  • 122.List of abbreviations